Why Fevertree Drinks plc is a top stock pick for 2018

Fevertree Drinks plc (LON:FEVR) appears as expensive as ever, but the firm looks to have more tricks up its sleeve.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It seems that since listing in 2014 Fevertree Drinks (LSE: FEVR) has consistently gone from strength to strength to become the £2.5bn market cap business it is today. By broadening its portfolio of premium mixers and convincing ever more bars and individuals to upgrade to its offerings, Fevertree has claimed a higher share of the UK drinks market than even the rosiest projections its IPO prospectus predicted were possible.

And although the company’s valuation of 66 times 2017 consensus earnings looks as pricey as the day it floated, I still believe Fevertree is a fantastic company and stock to own for the long haul. Much of my enthusiasm stems from the fact that the company’s co-founders still run the show, which gives me confidence that they can repeat their stunning success in the UK overseas.

And although the company continues to reliably double its UK sales period after period, there is no doubt overseas markets will become the company’s most important if it is to live up to its lofty valuation. Its announcement in December that it was ceasing its relationship with a third party distributor in North America in order to to directly control the expansion of its brand there lends credence to this theory.

To date, Fevertree has had little trouble recording consistent double-digit sales growth in North America, but growth there has been nowhere near as impressive as at home. Yet the rewards are mind-boggling if increased management attention to the huge American market can make its cola or ginger beer as popular in the US as its tonics are in the UK.

This is a lofty goal, but Fevertree’s founder-led management team, asset-light business model, superior products and fragmented competition all leave me confident that the business will continue to grow by leaps and bounds to live up to its rich valuation.

Time to be contrarian? 

A  domestic business with a more down-to-Earth valuation that also sees great potential in the US is food-to-go manufacturer Greencore (LSE: GNC). Dublin-headquartered Greencore is already the UK’s largest provider of ready made sandwiches and meals to the grocery sector and bulked up its operations Stateside last year through the $747m purchase of Peacock Foods.

This deal was transformative as it not only bulked up the company’s manufacturing facilities in the country, enabling the group to handle larger contracts for bigger customers. In addition, it opened up access to the vast US grocery market for the first time via legacy contracts with consumer goods giants such as Tyson.

The aforementioned contracts with Tyson have turned out to be a bit of a mixed blessing for Greencore though, as that company’s purchase of a rival food-to-go manufacturer has sparked fears that it will end contracts with Greencore. But with the two having co-invested in factories and having long-term contracts, there’s little fear of this happening out of the blue.

And with the business in the US growing volumes nicely and winning contracts, combined with stellar double-digit growth at home, market nervousness has made Greencore look incredibly cheap to me at 13 times forward earnings.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ian Pierce has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended Greencore. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Can the filthy cheap BP share price rocket in 2025? Here’s what the experts say

Harvey Jones took advantage of a tough year for the BP share price to add the stock to his portfolio…

Read more »

Investing Articles

I aim for a million buying just 10 or so shares!

Rather than investing in dozens of different companies, our writer is focussing on finding a few great ones to help…

Read more »

British Pennies on a Pound Note
Investing Articles

Has this 6% yielding penny share fallen too far?

After a testy few days for a penny share our writer holds, he revisits the investment case and weighs management…

Read more »

Investing Articles

These are the 3 top-yielding FTSE 250 stocks in my passive income portfolio

Mark Hartley explains why these three mid-cap stocks make good additions to his passive income portfolio, despite lacking the stability…

Read more »

Investing Articles

3 stock market pitfalls for beginners to look out for

When investing in the stock market it's easy to fall foul of these three big mistakes. Our writer considers some…

Read more »

Growth Shares

The second phase of AI’s started. I expect these UK shares to benefit

Edward Sheldon believes these UK shares could do well as artificial intelligence solutions are introduced within the corporate world.

Read more »

Investing Articles

How much will be needed to start buying shares in 2025?

Christopher Ruane explains why he thinks it need not cost the earth to start buying shares and details some considerations…

Read more »

Investing Articles

Can the Next share price defy the odds and grow another 25% next year?

Harvey Jones is in awe of the Next share price, which has shrugged off the troubles hitting retail for another…

Read more »